Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2016

Nov 8, 2016

34519_dirs_2016-11-08_02ab8cd1-3d61-4814-9b70-a5ab117f3834.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2016-11-07

Reporting Person: Tomsche David Scott (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-07 Common Stock, par value $0.10 per share P 4000.0000 $5.1900 Acquired 70789.0000 Direct

Footnotes

F1: (1) This figure includes 2,322 shares of common stock held by immediate family member of Dr. Tomsche.